Long Term Mortality Of Patients With Parkinson ? S Disease Treated With Deep Brain Stimulation In A Reference Center

Introduction: Parkinson's disease (PD) is a common neurodegenerative disorder, with a higher risk of death than general population. Deep Brain Stimulation (DBS) has been used to treat PD for more than 2 decades, but few studies exist concerning mortality in this subset of patients. Our goal is to analyse mortality in PD patients treated with DBS in our centre.Methods: retrospective evaluation of clinical files of patients with PD who underwent DBS surgery consecutively between October 2002 and May 2019.Results: 346 patients were included in the analysis, 60 % male, with a mean age at disease onset of 48 +/- 8 years (18-64), mean age at surgery of 60 +/- 7 years (33-75), and mean disease duration until surgery of 14 +/- 6 years (3-52). Mean follow-up after surgery was 7 +/- 4 years (range 1-17). Overall mortality rate was 17.9 % and mean age at time of death was 71 +/- 6 years. The main causes of death were pneumonia, dementia and acute myocardial infarction. In our series, male gender and disease duration until surgery were the only predictors of mortality in multivariate analysis.Conclusion: Our study showed a long-term survival higher than previously described, and suggests that the treatment of patients with shorter disease evolution might have a survival benefit. The leading causes of death in PD patients treated with DBS seems unrelated to surgery, as the main causes of death are comparable to non-DBS patients.